Transaction DateRecipientSharesTypePriceValue
16th September 2020Richard H Scheller25,000Open or private sale$37.50$937,500.00
15th September 2020Carl L Gordon292,607Grant/award etc.$0.00
15th September 2020Advisors Llc Orbimed292,607Grant/award etc.$0.00
15th September 2020Carl L Gordon4,822,960Grant/award etc.$0.00
15th September 2020Advisors Llc Orbimed4,822,960Grant/award etc.$0.00
15th September 2020Advisors Llc Orbimed902,885Grant/award etc.$0.00
15th September 2020Carl L Gordon902,885Grant/award etc.$0.00
21st August 2020David M. Wehner11,828Open or private sale$268.65$3,177,592.20
19th August 2020David M. Wehner1,832Open or private sale$261.39$478,866.48
19th August 2020Louis J Jr Lavigne6,218Exercise of derivative$0.00
Alector
Alector logo

Alector, Inc. develops therapeutics for the treatment of neurodegenerative diseases including frontotemporal dementia (FTD), Alzheimer's disease, and Parkinson's disease. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in 2013.

Ticker: ALEC
Sector: Healthcare
Industry: Biotechnology
SEC Central Index Key (CIK): 1653087
Employees:
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals